ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

GSK to invest in three U.K. facilities

by Rick Mullin
August 1, 2016 | APPEARED IN VOLUME 94, ISSUE 31

Britain’s decision to exit the European Union isn’t stopping GlaxoSmithKline from deciding to invest more than $350 million at three of its U.K. sites to boost production of new respiratory therapies and biologic medicines. GSK, which employs about 6,000 at nine U.K. manufacturing locations, will expand in Barnard Castle in County Durham, Eng­land; Montrose in Angus, Scotland; and Ware in Hertfordshire, England. The company says most of the products will be exported around the world.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment